diabetes glp-1 vs sglt2 Cardiovascular outcome studies in type 2 diabetes: Comparison between inhibitors and receptor agonists Cardiovascular benefits of SGLT2 inhibitors
Description
(The best results were seen in those who were overweight
This is the most definitive treatment approach and the one with the strongest evidence base
Klein S, Gastaldelli A, Yki-Jrvinen H, Scherer PE
GLP-1 analogs and weight regulation Weight control is key to combatting obesity and T2D
Our dietitian team is available to offer personalized support and guidance to help manage any concerns along the way
(6 months
